London-Based DeepMind Publishes Research on AI Protein Structure Prediction
DeepMind has expanded its AlphaFold Protein Structure Database, offering researchers access to millions of new protein structure predictions. This development supports scientific progress in fields such as drug discovery and biotechnology.
- Published date: 19-06-2026 10:01 AM
DeepMind, a London-based artificial intelligence company owned by Alphabet, has published new research detailing advancements in protein structure prediction using its AlphaFold system. The findings, released in June 2024, expand the database of predicted protein structures, providing valuable insights for the global scientific community.
The AlphaFold Protein Structure Database now includes over 250 million predicted structures, covering nearly every known protein sequence. This resource is freely accessible to researchers worldwide, supporting efforts in drug discovery, disease research, and biotechnology.
DeepMind's collaboration with the European Molecular Biology Laboratory (EMBL) has been instrumental in making these predictions widely available. The ongoing updates to the database reflect a commitment to open science and the acceleration of biological research through AI-driven tools.
DeepMind has expanded its AlphaFold Protein Structure Database, offering researchers access to millions of new protein structure predictions. This development supports scientific progress in fields such as drug discovery and biotechnology.